Completed NA INTERVENTIONAL 2-arm NCT01715649

Telehealth Remote Patient Monitoring Study in People With Type 2 Diabetes

Evaluation of a Telehealth Intervention Combining Structured Self-Monitoring of Blood Glucose and Nurse Care Coordination Among People With Type 2 Diabetes Noninsulin-Treated

Sponsor: GE Healthcare

Conditions Diabetes Mellitus, Type 2

Interventions Patient education, self-monitoring of blood glucose and remote patient monitoring of blood glucose

Updated 5 times since 2017 Last updated: Nov 17, 2014 Started: Nov 30, 2012 Primary completion: May 31, 2014 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Diabetes Mellitus, Type 2 and is currently completed. GE Healthcare leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GE Healthcare
LifeScan
Sutter Health
University of California, Davis

Data source: Sutter Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sacramento, United States